Tracking treatment for NTM lung disease in Korea
Part of Lungs & breathing clinical trials.
This study collects information from people starting treatment for a chronic lung infection caused by NTM bacteria. It helps doctors learn more about the disease and how different treatments work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed NTM lung infection (a chronic lung disease caused by certain bacteria).
- The bacteria causing your infection must be one of these types: M. avium complex, M. abscessus, or M. kansasii.
- You should be starting a new treatment plan for this infection.
- You can join even if you've had treatment before, but not if you've already been on treatment for more than 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will build a Canadian registry for people with bronchiectasis (not from cystic fibrosis) and NTM infections. The goal is to track health outcomes over time to improve care.
This study looks at how NTM bacteria spread among people. If you have had a positive NTM test from your lungs, you may be able to help by sharing a sample for research.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
This trial uses a simple symptom diary to monitor how people with lung NTM infections are feeling over time, either on or off antibiotics. It helps doctors understand treatment effects better.
Hear when a new Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.